Media Contacts

Ministry of Health

Media Relations
250 952-1887

Backgrounders

Progress in B.C. cancer care

Some key actions the Province has taken:

  • upgrading existing hospital space through renovation and expansion, including adding new diagnostic-imaging equipment, such as a new cyclotron and radiopharmacy laboratory in Vancouver that will be completed in 2026, increasing the production of clinical radiotracers, the radioactive isotopes used in medical imaging to detect and monitor cancers;
  • offering Chimeric Antigen Receptor T-Cell (CAR-T) therapy as of March 2024, an advanced immunotherapy, at Vancouver General Hospital and BC Children’s Hospital;
  • expanded travel programs for people living in rural and remote communities through Hope Air and Canadian Cancer Society;
  • launched a new cervix self-screening program to allow people to screen more privately and expanded HPV immunization campaigns, including extended eligibility for free, publicly funded vaccines to males turning 19 in 2024 who missed vaccination campaigns while in school;
  • expanding gynecological oncology surgical services to Kelowna and strengthening the teams providing care with more staff, including new gynecological oncologists; services are already available in Victoria and Vancouver, with planning in consideration for Surrey;
  • hiring new physicians and clinical support staff:
    • since April 1, 2023, B.C. has added 224.6 full-time equivalent (FTE) health-care providers to regional cancer centres, including in nursing, radiation therapy, pharmacy, supportive care, molecular imaging, clerical, and data roles;
    • as well, 56.7 FTE new physicians were hired since 2023, including 99 oncologists and 61 radiation therapists; 
    • eight Indigenous patient navigators now work in regional cancer centres in Abbotsford, Prince George, Surrey, Victoria, Kelowna, and Vancouver to support culturally safe care; and
  • BC Cancer has also expanded the use of innovative radiotherapy techniques to treat more patients faster; through adaptive treatments and precision radiotherapy, patients can receive fewer, more targeted treatments.